These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22294179)

  • 1. Testing for inverse agonism with constitutive receptor systems.
    Kenakin T
    Curr Protoc Pharmacol; 2006 Apr; Chapter 9():Unit9.5. PubMed ID: 22294179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing label-free biosensors for pharmacological screening with cell-based functional assays.
    Peters MF; Vaillancourt F; Heroux M; Valiquette M; Scott CW
    Assay Drug Dev Technol; 2010 Apr; 8(2):219-27. PubMed ID: 20085460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods to measure g-protein-coupled receptor activity for the identification of inverse agonists.
    Barreda-Gómez G; Teresa Giralt M; Rodríguez-Puertas R
    Methods Enzymol; 2010; 485():261-73. PubMed ID: 21050922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cAMP assays in GPCR drug discovery.
    Vasudevan NT
    Methods Cell Biol; 2017; 142():51-57. PubMed ID: 28964339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery.
    Bond RA; Ijzerman AP
    Trends Pharmacol Sci; 2006 Feb; 27(2):92-6. PubMed ID: 16406086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology.
    Yan YX; Boldt-Houle DM; Tillotson BP; Gee MA; D'Eon BJ; Chang XJ; Olesen CE; Palmer MA
    J Biomol Screen; 2002 Oct; 7(5):451-9. PubMed ID: 14599361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPCR assay automation for leveraging lead optimization.
    Cvijic ME; Chen J; Kubala S; Nolfo J; Kolodin G; Zhang L
    J Lab Autom; 2012 Aug; 17(4):266-74. PubMed ID: 22505604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tango assay for ligand-induced GPCR-β-arrestin2 interaction: Application in drug discovery.
    Dogra S; Sona C; Kumar A; Yadav PN
    Methods Cell Biol; 2016; 132():233-54. PubMed ID: 26928547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miniaturization of whole live cell-based GPCR assays using microdispensing and detection systems.
    Kornienko O; Lacson R; Kunapuli P; Schneeweis J; Hoffman I; Smith T; Alberts M; Inglese J; Strulovici B
    J Biomol Screen; 2004 Apr; 9(3):186-95. PubMed ID: 15140380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update of novel screening methods for GPCR in drug discovery.
    Chen L; Jin L; Zhou N
    Expert Opin Drug Discov; 2012 Sep; 7(9):791-806. PubMed ID: 22716301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular assays as portals to seven-transmembrane receptor-based drug discovery.
    Kenakin TP
    Nat Rev Drug Discov; 2009 Aug; 8(8):617-26. PubMed ID: 19609267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a cyclic adenosine monophosphate assay for Gi-coupled G protein-coupled receptors by utilizing the endogenous calcitonin activity in Chinese hamster ovary cells.
    Wang Y; Kong Y; Shei GJ; Kang L; Cvijic ME
    Assay Drug Dev Technol; 2011 Oct; 9(5):522-31. PubMed ID: 21561374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking and Virtual Screening Strategies for GPCR Drug Discovery.
    Beuming T; Lenselink B; Pala D; McRobb F; Repasky M; Sherman W
    Methods Mol Biol; 2015; 1335():251-76. PubMed ID: 26260606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cAMP Biosensor-Based High-Throughput Screening Assay for Identification of Gs-Coupled GPCR Ligands and Phosphodiesterase Inhibitors.
    Vedel L; Bräuner-Osborne H; Mathiesen JM
    J Biomol Screen; 2015 Aug; 20(7):849-57. PubMed ID: 25851033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo assessment of mu opioid receptor constitutive activity.
    Bilsky EJ; Giuvelis D; Osborn MD; Dersch CM; Xu H; Rothman RB
    Methods Enzymol; 2010; 484():413-43. PubMed ID: 21036244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin receptor: high constitutive activity and methods for developing inverse agonists.
    Els S; Beck-Sickinger AG; Chollet C
    Methods Enzymol; 2010; 485():103-21. PubMed ID: 21050913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex GPCR assay in reverse transfection cell microarrays.
    Mishina YM; Wilson CJ; Bruett L; Smith JJ; Stoop-Myer C; Jong S; Amaral LP; Pedersen R; Lyman SK; Myer VE; Kreider BL; Thompson CM
    J Biomol Screen; 2004 Apr; 9(3):196-207. PubMed ID: 15140381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Throughput Screening for Allosteric Modulators of GPCRs.
    Bertekap RL; Burford NT; Li Z; Alt A
    Methods Mol Biol; 2015; 1335():223-40. PubMed ID: 26260604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse agonism: the classic concept of GPCRs revisited [Review].
    Sato J; Makita N; Iiri T
    Endocr J; 2016 Jun; 63(6):507-14. PubMed ID: 26961122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of inverse agonism of the cannabinoid receptors.
    Fong TM
    Methods Enzymol; 2010; 485():139-45. PubMed ID: 21050915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.